These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 1373982)

  • 1. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
    Ericson SG; Colby E; Welch L; Ball ED
    Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation for acute myeloid leukemia following in vitro treatment with neuraminidase and monoclonal antibodies.
    Ball ED; Vredenburgh JJ; Mills LE; Cornwell GG; Schwarz L; Howell AL; Troy K
    Bone Marrow Transplant; 1990 Oct; 6(4):277-80. PubMed ID: 1982228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
    Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
    Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
    Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
    Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
    Jiang R; Han M; Zhao Y
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
    Ball ED; Wilson J; Phelps V; Neudorf S
    Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
    Tomás JF; Gómez-García de Soria V; Pinilla I; Lamana M; Figuera A; Arranz R; Cámara R; Fernández-Villalta MJ; Alegre A; Fernández-Rañada JM
    Med Clin (Barc); 1997 Feb; 108(6):201-6. PubMed ID: 9102484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies.
    Ball ED
    Bone Marrow Transplant; 1988 Sep; 3(5):387-92. PubMed ID: 3056546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
    Robertson MJ; Roy DC; Stone RM; Ritz J
    Prog Clin Biol Res; 1994; 389():47-63. PubMed ID: 7700916
    [No Abstract]   [Full Text] [Related]  

  • 16. Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue.
    Rhodes EG; Baker PK; Rhodes JM; Davies JM; Duguid JK
    Bone Marrow Transplant; 1994 Jun; 13(6):795-9. PubMed ID: 7522727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
    De Fabritiis P; Ferrero D; Sandrelli A; Tarella C; Meloni G; Pulsoni A; Pregno P; Badoni R; De Felice L; Gallo E
    Bone Marrow Transplant; 1989 Nov; 4(6):669-74. PubMed ID: 2819285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
    Bengtsson M; Tötterman TH; Smedmyr B; Festin R; Oberg G; Simonsson B
    Leukemia; 1989 Jan; 3(1):68-75. PubMed ID: 2535882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.